Clinical Trials Directory

Trials / Completed

CompletedNCT05140564

Safe Management of People With Type 1 Diabetes and EAting Disorders studY

Safe Management of People With Type 1 Diabetes and EAting Disorders studY - Phase II

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
King's College London · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There is currently no effective intervention for type 1 diabetes and eating disorders. The main objective of STEADY Stage 2 is to test the feasibility of the newly developed STEADY intervention. STEADY was co-designed by using Experience Based Co-Design methodology and other qualitative methods (focus groups, interviews). These findings informed the development of a T1DM cognitive behaviour therapy (CBT) manual. The intervention will now be tested in a feasibility Randomised Controlled Trial (RCT) in adults with type 1 diabetes and eating disorders and compared with usual clinical care. If STEADY is feasible, this may provide an effective intervention for this population. This study will take place at King's College London. Participants will remain in the study for 6 months, with a 12-month extended observation period. The study is expected to end in February 2023.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSTEADY interventionSTEADY is a novel Cognitive Behavioural Therapy (CBT) based intervention for eating disorders in type 1 diabetes.

Timeline

Start date
2022-01-18
Primary completion
2024-02-29
Completion
2024-02-29
First posted
2021-12-01
Last updated
2024-03-05

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05140564. Inclusion in this directory is not an endorsement.